Dr Lindsay Fraser, Chief Science and Operations Officer, and Dr Fernanda Masri, Chief Commercial and Innovation Officer, at Cytomos explore current advances in technology that are helping improve cell analysis within drug discovery. The biopharma industry is under increasing pressure to bring novel therapies to market, faster and more affordably. However, securing access to key […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!